Company / Assets per Share
Regeneron Pharmaceuticals Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$356.72
FY2025
5-year range
$221.94 / $356.72
FY2021-FY2025
Trend
+7.2%
vs FY2024
Sector context
#4 of 210
Health Care
What the data says
Among 210 Health Care companies, Regeneron Pharmaceuticals is in the top 2% for assets per share. Assets per Share has increased for 9 consecutive years, from $61.49 in FY2016 to $356.72 in FY2025.
Based on SEC 10-K filings.
356.72 in FY2025 with a 5-year CAGR of +19.0%. Top quartile in the Health Care sector.
Improved from $294.83 to $356.72 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +12.0%
- 5-Year CAGR
- +19.0%
- 10-Year CAGR
- -
Sector benchmark
Top 2% in Health CareTop 2% of 210This company $356.72 Sector average $353.16
▼
+1.0% above sector average
Key checks
Key Insights
- Regeneron Pharmaceuticals's assets per share has grown for 9 consecutive years.
- In FY2025, assets per share increased 7.2% year-over-year.
- Ranks #4 out of 210 companies in the Health Care sector.
- Lowest assets per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.03 (safe zone, above 2.9 threshold)
- Strong profit margin: 32.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $356.72 | +7.2% |
| FY2024 | $332.68 | +12.8% |
| FY2023 | $294.83 | +16.2% |
| FY2022 | $253.82 | +14.4% |
| FY2021 | $221.94 | +48.5% |
| FY2020 | $149.51 | +17.0% |
| FY2019 | $127.74 | +26.6% |
| FY2018 | $100.90 | +32.7% |
| FY2017 | $76.06 | +23.7% |
| FY2016 | $61.49 | +22.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026